MedPath

The effect of taking calcium and vitamin D on the rate af recurrence and severity of benign paroxysmal positional vertigo

Phase 2
Conditions
Benign paroxysmal vertigo.
Disorders of vestibular function
Registration Number
IRCT20170505033824N1
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
86
Inclusion Criteria

Diagnosis of peripheral vestibular lesions and proper cognition according to Hallpik test

Exclusion Criteria

Central lesions like stroke, Parkinson's disease, brain trauma according to a neurologist's diagnosis or history of psychiatric diseases or deformities that impair the balance, such as severe spinal deviation or deformity of the lower extremities
Addict and alcoholic people and pregnant women, as well as those who are not willing to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.;Duration of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.;Rate of recorrence of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath